AvenCell Therapeutics on Tuesday said it collected $112 million to continue clinical studies of two experimental acute ...

EDT Cathie Wood’s ARK Investment buys 255K shares of Cerus (CERS) today Published first on TheFly – the ultimate source for ...

On Friday, Cerus Corp (CERS) stock saw a modest uptick, ending the day at $1.7 which represents a slight increase of $0.07 or 4.29% from the prior close of $1.63. The stock opened at $1.63 and touched ...

As tensions with Tehran escalate, Alma Center pundits urge drying up the supply of weapons to Shiite terror group; warn that ...

In a report released today, William Bonello from Craig-Hallum maintained a Buy rating on Cerus (CERS – Research Report). The ...

Cerus (NASDAQ:CERS – Free Report) had its target price trimmed by Stifel Nicolaus from $6.00 to $3.00 in a report issued on Thursday morning, MarketBeat.com reports. The brokerage currently has a buy ...

Nurix Therapeutics’ BTK degrader has elicited responses in a small group of patients with certain cancers, supporting the ...

AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications ...

A new electrification project, set to impact 500 households in the 2515 postcode of New South Wales with energy transition, ...

Cerus Corporation (Nasdaq: CERS) today announced a selection of abstracts to be presented at the 2024 Association for the Advancement of Blood & Biotherapies (AABB) Annual Meeting, taking place in ...

Cerus Corporation (Nasdaq:CERS) today announced updates on the INTERCEPT red blood cell (RBC) programs in the U.S. and in Europe: ...

Stifel analyst Mathew Blackman lowered the firm’s price target on Cerus to $3 from $6 and keeps a Buy rating on the shares ...